Clinical Trials Browser

Neoplasms × Temozolomide × Dermatologic × Clear all

NCT00588341 2016-02-01

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Phase 2 Completed

24 enrolled 4 charts

Melanoma, Neoplasms, Skin Neoplasms